Is antagonism of α3β4 nicotinic receptors a strategy to reduce morphine dependence?

Olga D. Taraschenko, Vishal Panchal, Isabelle M. Maisonneuve, Stanley D. Glick

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

18-Methoxycoronaridine, a synthetic iboga alkaloid congener, has been previously shown to attenuate several signs of morphine withdrawal in rats. The recently discovered action of 18-methoxycoronaridine to block α3β4 nicotinic receptors may be responsible for this effect. To test this hypothesis the effects of non-selective α3β4 receptor antagonists, dextromethorphan, mecamylamine, bupropion, and their combinations, were assessed on of acute naltrexone-precipitated (1 mg/kg i.p.) morphine withdrawal in rats. Dextromethorphan (5-40 mg/kg, s.c.), mecamylamine (0.25-4 mg/kg, i.p.) and bupropion (10-30 mg/kg, i.p.) alone produced variable effects on signs of withdrawal. However, two low-dose combinations, i.e., dextromethorphan (5 mg/kg, s.c.) and mecamylamine (0.25 mg/kg, i.p.), mecamylamine (0.25 mg/kg, i.p.) and bupropion (10 mg/kg, i.p.) as well as the three-drug combination significantly attenuated diarrhea and weight loss; none of the agents administered alone had these effects. The results of the present study provide evidence that α3β4 nicotinic receptors are involved in the expression of at least two signs of opioid withdrawal.

Original languageEnglish (US)
Pages (from-to)207-218
Number of pages12
JournalEuropean Journal of Pharmacology
Volume513
Issue number3
DOIs
StatePublished - Apr 25 2005

Fingerprint

Morphine Dependence
Mecamylamine
Nicotinic Receptors
Dextromethorphan
Bupropion
Morphine
Tabernaemontana
Naltrexone
Drug Combinations
Alkaloids
Opioid Analgesics
Weight Loss
Diarrhea
18-methoxycoronaridine

Keywords

  • Bupropion
  • Dextromethorphan
  • Mecamylamine
  • Morphine
  • Naltrexone
  • Opioid withdrawal

ASJC Scopus subject areas

  • Pharmacology

Cite this

Is antagonism of α3β4 nicotinic receptors a strategy to reduce morphine dependence? / Taraschenko, Olga D.; Panchal, Vishal; Maisonneuve, Isabelle M.; Glick, Stanley D.

In: European Journal of Pharmacology, Vol. 513, No. 3, 25.04.2005, p. 207-218.

Research output: Contribution to journalArticle

Taraschenko, Olga D. ; Panchal, Vishal ; Maisonneuve, Isabelle M. ; Glick, Stanley D. / Is antagonism of α3β4 nicotinic receptors a strategy to reduce morphine dependence?. In: European Journal of Pharmacology. 2005 ; Vol. 513, No. 3. pp. 207-218.
@article{9f60028d1a414838841a9166ae66cfaf,
title = "Is antagonism of α3β4 nicotinic receptors a strategy to reduce morphine dependence?",
abstract = "18-Methoxycoronaridine, a synthetic iboga alkaloid congener, has been previously shown to attenuate several signs of morphine withdrawal in rats. The recently discovered action of 18-methoxycoronaridine to block α3β4 nicotinic receptors may be responsible for this effect. To test this hypothesis the effects of non-selective α3β4 receptor antagonists, dextromethorphan, mecamylamine, bupropion, and their combinations, were assessed on of acute naltrexone-precipitated (1 mg/kg i.p.) morphine withdrawal in rats. Dextromethorphan (5-40 mg/kg, s.c.), mecamylamine (0.25-4 mg/kg, i.p.) and bupropion (10-30 mg/kg, i.p.) alone produced variable effects on signs of withdrawal. However, two low-dose combinations, i.e., dextromethorphan (5 mg/kg, s.c.) and mecamylamine (0.25 mg/kg, i.p.), mecamylamine (0.25 mg/kg, i.p.) and bupropion (10 mg/kg, i.p.) as well as the three-drug combination significantly attenuated diarrhea and weight loss; none of the agents administered alone had these effects. The results of the present study provide evidence that α3β4 nicotinic receptors are involved in the expression of at least two signs of opioid withdrawal.",
keywords = "Bupropion, Dextromethorphan, Mecamylamine, Morphine, Naltrexone, Opioid withdrawal",
author = "Taraschenko, {Olga D.} and Vishal Panchal and Maisonneuve, {Isabelle M.} and Glick, {Stanley D.}",
year = "2005",
month = "4",
day = "25",
doi = "10.1016/j.ejphar.2005.03.005",
language = "English (US)",
volume = "513",
pages = "207--218",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Is antagonism of α3β4 nicotinic receptors a strategy to reduce morphine dependence?

AU - Taraschenko, Olga D.

AU - Panchal, Vishal

AU - Maisonneuve, Isabelle M.

AU - Glick, Stanley D.

PY - 2005/4/25

Y1 - 2005/4/25

N2 - 18-Methoxycoronaridine, a synthetic iboga alkaloid congener, has been previously shown to attenuate several signs of morphine withdrawal in rats. The recently discovered action of 18-methoxycoronaridine to block α3β4 nicotinic receptors may be responsible for this effect. To test this hypothesis the effects of non-selective α3β4 receptor antagonists, dextromethorphan, mecamylamine, bupropion, and their combinations, were assessed on of acute naltrexone-precipitated (1 mg/kg i.p.) morphine withdrawal in rats. Dextromethorphan (5-40 mg/kg, s.c.), mecamylamine (0.25-4 mg/kg, i.p.) and bupropion (10-30 mg/kg, i.p.) alone produced variable effects on signs of withdrawal. However, two low-dose combinations, i.e., dextromethorphan (5 mg/kg, s.c.) and mecamylamine (0.25 mg/kg, i.p.), mecamylamine (0.25 mg/kg, i.p.) and bupropion (10 mg/kg, i.p.) as well as the three-drug combination significantly attenuated diarrhea and weight loss; none of the agents administered alone had these effects. The results of the present study provide evidence that α3β4 nicotinic receptors are involved in the expression of at least two signs of opioid withdrawal.

AB - 18-Methoxycoronaridine, a synthetic iboga alkaloid congener, has been previously shown to attenuate several signs of morphine withdrawal in rats. The recently discovered action of 18-methoxycoronaridine to block α3β4 nicotinic receptors may be responsible for this effect. To test this hypothesis the effects of non-selective α3β4 receptor antagonists, dextromethorphan, mecamylamine, bupropion, and their combinations, were assessed on of acute naltrexone-precipitated (1 mg/kg i.p.) morphine withdrawal in rats. Dextromethorphan (5-40 mg/kg, s.c.), mecamylamine (0.25-4 mg/kg, i.p.) and bupropion (10-30 mg/kg, i.p.) alone produced variable effects on signs of withdrawal. However, two low-dose combinations, i.e., dextromethorphan (5 mg/kg, s.c.) and mecamylamine (0.25 mg/kg, i.p.), mecamylamine (0.25 mg/kg, i.p.) and bupropion (10 mg/kg, i.p.) as well as the three-drug combination significantly attenuated diarrhea and weight loss; none of the agents administered alone had these effects. The results of the present study provide evidence that α3β4 nicotinic receptors are involved in the expression of at least two signs of opioid withdrawal.

KW - Bupropion

KW - Dextromethorphan

KW - Mecamylamine

KW - Morphine

KW - Naltrexone

KW - Opioid withdrawal

UR - http://www.scopus.com/inward/record.url?scp=18144363261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144363261&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2005.03.005

DO - 10.1016/j.ejphar.2005.03.005

M3 - Article

C2 - 15862802

AN - SCOPUS:18144363261

VL - 513

SP - 207

EP - 218

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -